Rahul Khara is CLO at Disc Medicine, Inc. (IRON). They have made 4 open-market trades across 1 company since 2023, most recently 2026-08-06.
CIK 0001951850
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IRON | 52,324 | $3.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IRON | SELL · 10b5-1 | 2026-08-06 | 2026-08-07 | $80.00 | $400K | +3.3% | -1.2% | — |
| IRON | SELL · 10b5-1 | 2026-06-26 | 2026-06-30 | $75.00 | $188K | +4.0% | +8.4% | -11.1% |
| IRON | SELL · 10b5-1 | 2026-06-18 | 2026-06-23 | $70.22 | $527K | +8.2% | +6.6% | -3.7% |
| IRON | SELL | 2026-02-17 | 2026-02-17 | $62.86 | $179K | +4.5% | -7.2% | +4.9% |
| IRON | SELL | 2026-01-20 | 2026-01-21 | $69.74 | $70K | +8.7% | -17.3% | -6.9% |
| IRON | SELL | 2026-01-02 | 2026-01-05 | $78.69 | $511K | -8.4% | +5.2% | -15.2% |
| IRON | SELL | 2025-02-18 | 2025-02-20 | $54.58 | $127K | +0.5% | -2.5% | -11.3% |
| IRON | SELL · 10b5-1 | 2025-02-03 | 2025-02-04 | $55.55 | $833K | -0.7% | +1.9% | -10.8% |
| IRON | SELL · 10b5-1 | 2025-01-02 | 2025-01-06 | $62.75 | $471K | -7.4% | -11.0% | -37.7% |
| IRON | SELL · 10b5-1 | 2023-11-22 | 2023-11-27 | $51.74 | $517K | +8.5% | +9.2% | +21.8% |
| IRON | SELL · 10b5-1 | 2023-11-14 | 2023-11-15 | $50.58 | $456K | +3.9% | +12.6% | +27.4% |
| IRON | SELL · 10b5-1 | 2023-11-03 | 2023-11-07 | $50.00 | $5K | +5.7% | +17.1% | +42.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.